These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics. Persson CG Agents Actions Suppl; 1983; 13():115-29. PubMed ID: 6346831 [No Abstract] [Full Text] [Related]
6. Anti asthmatic effects and pharmacokinetics of enprofylline--a new xanthine derivate. Laursen LC Dan Med Bull; 1987 Dec; 34(6):289-97. PubMed ID: 3325233 [No Abstract] [Full Text] [Related]
7. [Methylxanthine preparations in the therapy of bronchial asthma]. Fedoseev GB; Kriakunov KN; Leĭchenko LV; Evartau EE Ter Arkh; 1987; 59(7):131-5. PubMed ID: 3313783 [No Abstract] [Full Text] [Related]
8. Development of safer xanthine drugs for treatment of obstructive airways disease. Persson CG J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):817-24. PubMed ID: 3534062 [TBL] [Abstract][Full Text] [Related]
10. Differences in the anti-inflammatory effects of theophylline and pentoxifylline: important for the development of asthma therapy? Entzian P; Bitter-Suermann S; Burdon D; Ernst M; Schlaak M; Zabel P Allergy; 1998 Aug; 53(8):749-54. PubMed ID: 9722223 [TBL] [Abstract][Full Text] [Related]
11. Xanthines--symptomatic or prophylactic in asthma? Persson CG; Erjefält I; Gustafsson B Agents Actions Suppl; 1988; 23():137-55. PubMed ID: 2902763 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies. Skorodin MS Arch Intern Med; 1993 Apr; 153(7):814-28. PubMed ID: 8096690 [TBL] [Abstract][Full Text] [Related]
13. Enprofylline, a principally new antiasthmatic xanthine. Persson CG; Kjellin G Acta Pharmacol Toxicol (Copenh); 1981 Oct; 49(4):313-6. PubMed ID: 7342692 [No Abstract] [Full Text] [Related]
14. The changing role of theophylline in pediatric asthma. Stoloff SW Am Fam Physician; 1994 Mar; 49(4):839-44. PubMed ID: 8116518 [TBL] [Abstract][Full Text] [Related]
15. [Effects of theopek and saltos on cardiorespiratory system in bronchial asthma]. Kirillov MM; Shapovalova TG; Riabova AIu; Smoliak SB; Bochkareva LE; Kurnosova OF; Kazban OG Klin Med (Mosk); 1999; 77(11):37-9. PubMed ID: 10635631 [TBL] [Abstract][Full Text] [Related]
16. Bronchodilatory effect of Carum copticum in airways of asthmatic patients. Boskabady MH; Alizadeh M; Jahanbin B Therapie; 2007; 62(1):23-9. PubMed ID: 17374344 [TBL] [Abstract][Full Text] [Related]
17. The Use of X Rays in the Treatment of Bronchial Asthma: A Historical Assessment. Calabrese EJ; Dhawan G; Kapoor R Radiat Res; 2015 Aug; 184(2):180-92. PubMed ID: 26207685 [TBL] [Abstract][Full Text] [Related]
18. [The xanthines: status in the therapeutic arsenal in 1990]. Chevrolet JC Schweiz Rundsch Med Prax; 1990 May; 79(22):694-7. PubMed ID: 2190297 [TBL] [Abstract][Full Text] [Related]
19. Effect of theophylline withdrawal on airway inflammation in asthma. Minoguchi K; Kohno Y; Oda N; Wada K; Miyamoto M; Yokoe T; Hashimoto T; Akabane T; Kobayashi H; Mita S; Kihara N; Adachi M Clin Exp Allergy; 1998 Aug; 28 Suppl 3():57-63. PubMed ID: 9756188 [TBL] [Abstract][Full Text] [Related]
20. [Effect of slow-release theophylline on airway inflammation in bronchial asthma]. Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]